Moquiala, Danilo F.
HRN: 21 41 08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
CEFTRIAXONE 1G (VIAL)
05/29/2022
06/05/2022
IV
2g
OD
Typhoid IgM
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes